ZURICH (Reuters) – Swiss drugmaker Novartis wants to buy the rest of the world’s biggest eye care firm Alcon for $39.3 billion, including Nestle’s majority stake, to help it diversify away from prescription drugs.

Read the rest here:
Novartis aims for full Alcon takeover for $39 billion